Skip to main content
. 2025 Dec 5;12:1693941. doi: 10.3389/fcvm.2025.1693941

Table 2.

Cardiopulmonary ultrasound indicators and cardiac coupled ultrasound indicators.

Parameter CHF-CPE group (n = 58) CHF-pneumonia group (n = 75) CHF-control group (n = 30) P-value
IVCDmax, mm 20.84 ± 3.94 17.41 ± 4.22a 15.38 ± 3.90a,b <0.001
IVC-V, % 25.95 (19.97, 33.46) 43.88 (31.62, 53.25)a 44.17 (38.53, 56.81)a <0.001
LAD, mm 44.00 (41.00, 47.00) 43.00 (40.00, 47.00) 45.50 (40.00, 48.00) 0.687
LAAmax, cm2 23.30 (20.30, 27.88) 22.10 (19.30, 24.60) 21.05 (19.28, 24.03) 0.054
LAAmin, cm2 18.60 (16.00,22.93) 15.90 (13.20, 18.70)a 14.20 (12.75, 17.63)a <0.001
LAA-V, % 21.53 (15.73, 25.59) 28.75 (22.07, 33.47)a 30.14 (28.05, 33.59)a <0.001
LVEDV, mL 132.50 (111.75, 161.75) 124 (97.00, 154.00) 124 (107.00, 154.00) 0.570
E, cm/s 113.00 (96.00, 128.25) 83.00 (69.00, 104.00)a 70.00 (63.75, 90.25)a <0.001
A, cm/s 70.00 (42.00, 101.00) 67.00 (49.00, 93.00) 60.00 (40.00, 85.25) 0.453
Septal e’, cm/s 5.00 (3.98, 5.83) 5.20 (4.60, 6.30)a 5.95 (4.65, 7.00)a 0.002
Lateral e’, cm/s 7.05 (6.00, 8.00) 8.20 (7.00, 9.00)a 8.35 (7.18, 9.95)a <0.001
E/A 1.61 (1.14, 2.55) 1.34 (0.78, 1.98)a 1.27 (0.64, 2.13)a 0.019
E/e’ 19.36 (16.81, 22.32) 13.18 (10.80, 15.42) a 10.16 (8.62, 12.94)a <0.001
LVEF, % 46.00 (37.00, 59.25) 47.00 (39.00, 59.00) 48.00 (39.00, 59.00) 0.925
TAPSE, mm 19.10 (16.28, 21.53) 17.50 (15.50, 20.90) 18.35 (15.60, 20.08) 0.433
MAPSE, mm 9.40 (7.80,11.65) 11.90 (9.10, 14.30)a 10.45 (8.90, 13.80) 0.005
TAPSE/MAPSE 1.94 (1.62, 2.37) 1.58 (1.31, 1.86)a 1.81 (1.37, 1.90)a <0.001
RV-s', cm/s 12.65 (9.95, 15.00) 11.30 (10.10, 14.10) 12.15 (9.83, 14.23) 0.712
TRV, m/s 3.00 (2.80, 3.30) 2.80 (2.40, 3.30) 2.45 (2.08, 2.80)a,b 0.001
PASP, mm Hg 48.64 (39.36, 57.39) 41.44 (31.04, 53.44)a 31.60 (24.12, 39.36)a,b <0.001
LVOT-VTI, cm 13.45 (10.88, 17.38) 16.20 (13.40, 19.40)a 14.15 (12.30, 20.33) 0.004
RVOT-VTI, cm 14.25 (12.10, 19.10) 15.00 (12.50, 17.90) 13.85 (10.90, 18.98) 0.604
RVSV, mL 70.17 (61.03, 85.82) 69.18 (57.31, 82.75) 65.46 (49.12, 85.99) 0.529
LVSV, mL 53.07 (41.55, 63.78) 65.08 (53.69, 75.07)a 66.80 (52.07, 86.91)a <0.001
ΔSV, mL 17.50 (10.29, 28.70) 5.59 (−4.20, 13.50) a −2.67 (−6.45, 5.15)a <0.001
LUS score, score 14.00 (10.00, 18.00) 10.00 (7.00, 14.00) <0.001
a

P < 0.05, compared with CHF-CPE group.

b

P < 0.05, compared with CHF-pneumonia group.

IVCD, inferior vena cava diameter; IVC-V, variation rate of inferior vena cava; LAD, left atrial diameter; LAA, left atrial area; LAA-V, variation of left atrial area; LVEDV, left ventricular end diastolic volume; E, early diastolic peak flow velocities of the mitral valve; A, late diastolic peak flow velocities of the mitral valve; e′, peak diastolic velocities of the mitral annulus; LVEF, left ventricular ejection fraction; TAPSE, tricuspid annular plane systolic excursion; MAPSE, mitral annular plane systolic excursion; RV-s’, right ventricular s’; TRV, tricuspid regurgitation velocity; PASP, pulmonary artery systolic pressure; LVOT-VTI, left ventricular outflow tract velocity time integral; RVOT-VTI, right ventricular outflow tract velocity time integral; RVSV, right ventricular stroke volume; LVSV, left ventricular stroke volume; ΔSV, The difference value between right ventricular stroke volume and left ventricular stroke volume; LUS, lung ultrasound.